1Hartley DM, Walsh DM, Ye CP, et al. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons [J]. J Neurosci, 1999,19(20):8876-8884.
2Green J, Goldsbury C, Mini T, et al. Fun-length rat amylin forms fibrils following substitution of single residues from human amylin[J]. J Mol Biol, 2003,326(4):1147-1156.
3Jaikaran ET, Clark A. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology[J]. Biochim Biophys Acta, 2001,1537(3):179-203.
4Wang F, Hull RL, Vidal J, et od. Islet amyloid develops diffusely throughout the pancreas before becoming severe and replacing endocrine cells[J]. Diabetes, 2001,50(11):2514-2520.
5Clark A, Nilsson MR. Islet amyloid: a complication of islet dysfunction or an aetiological factor in type 2 diabetes [J]? Diabetologia, 2004,47(2):157-169.
6Kayed R, Bemhagen J, Greenfield N, et al. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro[J] .J Mol Biol, 1999,287(4):781-796.
7Jaikaran ET, Nilsson MR, Clark A. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation[J]. Biochem J,2004,377(Pt 3):709-716.
8Nilsson MR, Driscoll M, Raleigh DP. Low levels of asparagine deamidation can have a dramatic effect on aggregation of amyloidogenic peptides: implications for the study of amyloid formation[J]. Protein Sci,2002,11(2):342-349.
9Jaikaran ET, Higham CE, Serpell LC, et al. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis [J]. J Mol Biol, 2001,308(3):515-525.
10Lee SC,Hashim Y,Li JK, et al. The islet amyloid polypeptide (amylin) gene S20G mutation in Chinese subjects: evidence for associations with type 2 diabetes and cholesterol levels[J]. Clin Endocrinol,2001,54(4):541-546.
5Westermark P, Wernstcdt C, Wilander E, et al. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA, 1987, 84(11): 3881-5.
6Kumar S, Miranker AD. A foldamer approach to targeting membrane bound helical states of islet amyloid polypeptide. Chem Commun, 2013, 49(42): 4749-51.
7Betsholtz C, Christmansson L, Engstrom U, et al. Sequence divergence in a specific region of islet amyloid polypeptide (lAPP) explains differences in islet amyloid formation between species. FEBS Lett, 1989, 251(1-2): 261-4.
8Caillon L, Lequin O, Khemtemourian L. Evaluation of membrane models and their composition for islet amyloid polypeptide-membrane aggregation. Biochim Biophys Acta, 2013, 1828(9): 2091-8.
9Harper JD, Lansbury PJ. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem, 1997, 66:385-407.
10Naiki H, Higuchi K, Hosokawa M, et al. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin TI. Anal Biochem, 1989, 177(2): 244-9.
